| Ticker | Action | Number of Shares Bought/Sold | Value of Shares Added/Sold | Average Price paid for previous share BUYs |
|---|
| ROG.SW - | BUY | 19,951 @ CHF 384.92 | CHF 7,679,539 | The ETF bought 19951 new shares of ROG.SW (). The shares were bought for an average price of 384.92 compared to the previous average buy price of 326.825. This is 17.8% higher than average price of previous purchases of ROG.SW. |
| EL.PA - EssilorLuxottica SA | BUY | 13,783 @ EUR 350.151 | EUR 4,826,131 | The ETF bought 13783 new shares of EL.PA (EssilorLuxottica SA). The shares were bought for an average price of 350.151 compared to the previous average buy price of 319.485. This is 9.6% higher than average price of previous purchases of EL.PA. |
| ABBV - AbbVie Inc | BUY | 16,968 @ USD 229.51 | USD 3,894,326 | The ETF bought 16968 new shares of ABBV (AbbVie Inc). The shares were bought for an average price of 229.51 compared to the previous average buy price of 200.201. This is 14.6% higher than average price of previous purchases of ABBV. |
| DHR - Danaher Corporation | BUY | 15,033 @ USD 226.98 | USD 3,412,190 | The ETF bought 15033 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 226.98 compared to the previous average buy price of 198.961. This is 14.1% higher than average price of previous purchases of DHR. |
| DHR - Danaher Corporation | BUY | 15,033 @ USD 226.98 | USD 3,412,190 | The ETF bought 15033 new shares of DHR (Danaher Corporation). The shares were bought for an average price of 226.98 compared to the previous average buy price of 198.961. This is 14.1% higher than average price of previous purchases of DHR. |
| SYK - Stryker Corporation | BUY | 8,582 @ USD 370.22 | USD 3,177,228 | The ETF bought 8582 new shares of SYK (Stryker Corporation). The shares were bought for an average price of 370.22 compared to the previous average buy price of 370.895. This is -0.2% lower than average price of previous purchases of SYK. |
| SAN.PA - Sanofi SA | BUY | 31,116 @ EUR 99.0961 | EUR 3,083,474 | The ETF bought 31116 new shares of SAN.PA (Sanofi SA). The shares were bought for an average price of 99.0961 compared to the previous average buy price of 98.7196. This is 0.4% higher than average price of previous purchases of SAN.PA. |
| MRK - Marks Electrical Group PLC | BUY | 30,189 @ USD 100.4 | USD 3,030,976 | The ETF bought 30189 new shares of MRK (Marks Electrical Group PLC). The shares were bought for an average price of 100.4 compared to the previous average buy price of 79.8418. This is 25.7% higher than average price of previous purchases of MRK. |
| MRK - Merck & Company Inc | BUY | 30,189 @ USD 100.4 | USD 3,030,976 | The ETF bought 30189 new shares of MRK (Merck & Company Inc). The shares were bought for an average price of 100.4 compared to the previous average buy price of 79.8418. This is 25.7% higher than average price of previous purchases of MRK. |
| LLY - Eli Lilly and Company | BUY | 2,722 @ USD 1070.16 | USD 2,912,976 | The ETF bought 2722 new shares of LLY (Eli Lilly and Company). The shares were bought for an average price of 1070.16 compared to the previous average buy price of 802.425. This is 33.4% higher than average price of previous purchases of LLY. |
| GSK.L - GlaxoSmithKline PLC | BUY | 122,078 @ GBP 23.4969 | GBP 2,868,455 | The ETF bought 122078 new shares of GSK.L (GlaxoSmithKline PLC). The shares were bought for an average price of 23.4969 compared to the previous average buy price of 21.5231. This is 9.2% higher than average price of previous purchases of GSK.L. |
| MTD - Mettler-Toledo International Inc | BUY | 1,881 @ USD 1470.14 | USD 2,765,333 | The ETF bought 1881 new shares of MTD (Mettler-Toledo International Inc). The shares were bought for an average price of 1470.14 compared to the previous average buy price of 1320.86. This is 11.3% higher than average price of previous purchases of MTD. |
| MTD - AMUNDI EUR GOV 710 | BUY | 1,881 @ USD 1470.14 | USD 2,765,333 | The ETF bought 1881 new shares of MTD (AMUNDI EUR GOV 710). The shares were bought for an average price of 1470.14 compared to the previous average buy price of 1320.86. This is 11.3% higher than average price of previous purchases of MTD. |
| AMGN - Amgen Inc | BUY | 8,186 @ USD 334.3 | USD 2,736,580 | The ETF bought 8186 new shares of AMGN (Amgen Inc). The shares were bought for an average price of 334.3 compared to the previous average buy price of 290.429. This is 15.1% higher than average price of previous purchases of AMGN. |
| REGN - Regeneron Pharmaceuticals Inc | BUY | 3,571 @ USD 761.45 | USD 2,719,138 | The ETF bought 3571 new shares of REGN (Regeneron Pharmaceuticals Inc). The shares were bought for an average price of 761.45 compared to the previous average buy price of 597.184. This is 27.5% higher than average price of previous purchases of REGN. |
| ISRG - Intuitive Surgical Inc | BUY | 4,206 @ USD 568.48 | USD 2,391,027 | The ETF bought 4206 new shares of ISRG (Intuitive Surgical Inc). The shares were bought for an average price of 568.48 compared to the previous average buy price of 530.514. This is 7.2% higher than average price of previous purchases of ISRG. |
| ARGX.BR - Argenx SE | BUY | 2,499 @ EUR 905.758 | EUR 2,263,489 | The ETF bought 2499 new shares of ARGX.BR (Argenx SE). The shares were bought for an average price of 905.758 compared to the previous average buy price of 717.419. This is 26.3% higher than average price of previous purchases of ARGX.BR. |
| UNH - UnitedHealth Group Incorporated | BUY | 6,223 @ USD 319.05 | USD 1,985,448 | The ETF bought 6223 new shares of UNH (UnitedHealth Group Incorporated). The shares were bought for an average price of 319.05 compared to the previous average buy price of 320.878. This is -0.6% lower than average price of previous purchases of UNH. |
| CSL.AX - | BUY | 15,499 @ AUD 118.158 | AUD 1,831,331 | The ETF bought 15499 new shares of CSL.AX (). The shares were bought for an average price of 118.158 compared to the previous average buy price of 133.24. This is -11.3% lower than average price of previous purchases of CSL.AX. |
| BMY - Bloomsbury Publishing Plc | BUY | 36,182 @ USD 47.76 | USD 1,728,052 | The ETF bought 36182 new shares of BMY (Bloomsbury Publishing Plc). The shares were bought for an average price of 47.76 compared to the previous average buy price of 47.135. This is 1.3% higher than average price of previous purchases of BMY. |
| JNJ - Johnson & Johnson | BUY | 5,810 @ USD 206.05 | USD 1,197,151 | The ETF bought 5810 new shares of JNJ (Johnson & Johnson). The shares were bought for an average price of 206.05 compared to the previous average buy price of 167.619. This is 22.9% higher than average price of previous purchases of JNJ. |
| ALNY - Alnylam Pharmaceuticals Inc | BUY | 2,685 @ USD 434.23 | USD 1,165,908 | The ETF bought 2685 new shares of ALNY (Alnylam Pharmaceuticals Inc). The shares were bought for an average price of 434.23 compared to the previous average buy price of 414.462. This is 4.8% higher than average price of previous purchases of ALNY. |
| GALD.SW - | BUY | 6,219 @ CHF 185.341 | CHF 1,152,636 | The ETF bought 6219 new shares of GALD.SW (). The shares were bought for an average price of 185.341 compared to the previous average buy price of 173.382. This is 6.9% higher than average price of previous purchases of GALD.SW. |
| CVS - CVS Health Corp | BUY | 14,345 @ USD 77.9 | USD 1,117,476 | The ETF bought 14345 new shares of CVS (CVS Health Corp). The shares were bought for an average price of 77.9 compared to the previous average buy price of 68.9166. This is 13.0% higher than average price of previous purchases of CVS. |
| COO - The Cooper Companies, Inc. Common Stock | BUY | 14,503 @ USD 76.01 | USD 1,102,373 | The ETF bought 14503 new shares of COO (The Cooper Companies, Inc. Common Stock). The shares were bought for an average price of 76.01 compared to the previous average buy price of 70.4094. This is 8.0% higher than average price of previous purchases of COO. |
| BIIB - Biogen Inc | BUY | 5,968 @ USD 176.82 | USD 1,055,262 | The ETF bought 5968 new shares of BIIB (Biogen Inc). The shares were bought for an average price of 176.82 compared to the previous average buy price of 145.122. This is 21.8% higher than average price of previous purchases of BIIB. |
| PFE - Pfizer Inc | BUY | 38,719 @ USD 25.22 | USD 976,493 | The ETF bought 38719 new shares of PFE (Pfizer Inc). The shares were bought for an average price of 25.22 compared to the previous average buy price of 24.6309. This is 2.4% higher than average price of previous purchases of PFE. |
| SIG.AX - | BUY | 510,248 @ AUD 1.89234 | AUD 965,563 | The ETF bought 510248 new shares of SIG.AX (). The shares were bought for an average price of 1.89234 compared to the previous average buy price of 1.98246. This is -4.5% lower than average price of previous purchases of SIG.AX. |
| INCY - Incyte Corporation | BUY | 8,558 @ USD 106.24 | USD 909,202 | The ETF bought 8558 new shares of INCY (Incyte Corporation). The shares were bought for an average price of 106.24 compared to the previous average buy price of 86.8418. This is 22.3% higher than average price of previous purchases of INCY. |
| MDT - Medtronic PLC | BUY | 6,263 @ USD 103.2 | USD 646,342 | The ETF bought 6263 new shares of MDT (Medtronic PLC). The shares were bought for an average price of 103.2 compared to the previous average buy price of 91.9031. This is 12.3% higher than average price of previous purchases of MDT. |
| HLN.L - Haleon PLC | BUY | 115,965 @ GBP 4.86965 | GBP 564,709 | The ETF bought 115965 new shares of HLN.L (Haleon PLC). The shares were bought for an average price of 4.86965 compared to the previous average buy price of 4.93096. This is -1.2% lower than average price of previous purchases of HLN.L. |
| ABT - Abbott Laboratories | BUY | 4,344 @ USD 127.19 | USD 552,513 | The ETF bought 4344 new shares of ABT (Abbott Laboratories). The shares were bought for an average price of 127.19 compared to the previous average buy price of 131.923. This is -3.6% lower than average price of previous purchases of ABT. |
| STMN.SW - | BUY | 4,374 @ CHF 122.199 | CHF 534,498 | The ETF bought 4374 new shares of STMN.SW (). The shares were bought for an average price of 122.199 compared to the previous average buy price of 117.022. This is 4.4% higher than average price of previous purchases of STMN.SW. |
| PODD - Insulet Corporation | BUY | 1,546 @ USD 337.53 | USD 521,821 | The ETF bought 1546 new shares of PODD (Insulet Corporation). The shares were bought for an average price of 337.53 compared to the previous average buy price of 311.94. This is 8.2% higher than average price of previous purchases of PODD. |
| RMD - ResMed Inc | BUY | 953 @ USD 250.52 | USD 238,746 | The ETF bought 953 new shares of RMD (ResMed Inc). The shares were bought for an average price of 250.52 compared to the previous average buy price of 262.755. This is -4.7% lower than average price of previous purchases of RMD. |
| TMO - Time Out Group plc | BUY | 251 @ USD 586.07 | USD 147,104 | The ETF bought 251 new shares of TMO (Time Out Group plc). The shares were bought for an average price of 586.07 compared to the previous average buy price of 476.092. This is 23.1% higher than average price of previous purchases of TMO. |
| ZTS - Zoetis Inc | BUY | 1,012 @ USD 122.87 | USD 124,344 | The ETF bought 1012 new shares of ZTS (Zoetis Inc). The shares were bought for an average price of 122.87 compared to the previous average buy price of 140.053. This is -12.3% lower than average price of previous purchases of ZTS. |
| SOBI.ST - | BUY | 2,847 @ SEK 35.226 | SEK 100,288 | The ETF bought 2847 new shares of SOBI.ST (). The shares were bought for an average price of 35.226 compared to the previous average buy price of 31.3147. This is 12.5% higher than average price of previous purchases of SOBI.ST. |
| SHL.AX - | BUY | 6,098 @ AUD 15.2033 | AUD 92,710 | The ETF bought 6098 new shares of SHL.AX (). The shares were bought for an average price of 15.2033 compared to the previous average buy price of 14.922. This is 1.9% higher than average price of previous purchases of SHL.AX. |
| BAX - Baxter International Inc | BUY | 4,548 @ USD 18.18 | USD 82,683 | The ETF bought 4548 new shares of BAX (Baxter International Inc). The shares were bought for an average price of 18.18 compared to the previous average buy price of 22.4144. This is -18.9% lower than average price of previous purchases of BAX. |
| DXCM - DexCom Inc | BUY | 1,101 @ USD 62.21 | USD 68,493 | The ETF bought 1101 new shares of DXCM (DexCom Inc). The shares were bought for an average price of 62.21 compared to the previous average buy price of 71.2254. This is -12.7% lower than average price of previous purchases of DXCM. |
| BIM.PA - BioMerieux | BUY | 523 @ EUR 125.326 | EUR 65,545 | The ETF bought 523 new shares of BIM.PA (BioMerieux). The shares were bought for an average price of 125.326 compared to the previous average buy price of 129.938. This is -3.5% lower than average price of previous purchases of BIM.PA. |
| SOON.SW - | BUY | 239 @ CHF 243.407 | CHF 58,174 | The ETF bought 239 new shares of SOON.SW (). The shares were bought for an average price of 243.407 compared to the previous average buy price of 277.372. This is -12.2% lower than average price of previous purchases of SOON.SW. |
| HIK.L - | BUY | 2,723 @ GBP 21.0738 | GBP 57,384 | The ETF bought 2723 new shares of HIK.L (). The shares were bought for an average price of 21.0738 compared to the previous average buy price of 24.0663. This is -12.4% lower than average price of previous purchases of HIK.L. |
| COLO-B.CO - | BUY | 595 @ DKK 89.385 | DKK 53,184 | The ETF bought 595 new shares of COLO-B.CO (). The shares were bought for an average price of 89.385 compared to the previous average buy price of 92.4036. This is -3.3% lower than average price of previous purchases of COLO-B.CO. |
| QIA.DE - QIAGEN NV | BUY | 1,022 @ EUR 47.3344 | EUR 48,376 | The ETF bought 1022 new shares of QIA.DE (QIAGEN NV). The shares were bought for an average price of 47.3344 compared to the previous average buy price of 45.6658. This is 3.7% higher than average price of previous purchases of QIA.DE. |
| RO.SW - | BUY | 118 @ CHF 397.672 | CHF 46,925 | The ETF bought 118 new shares of RO.SW (). The shares were bought for an average price of 397.672 compared to the previous average buy price of 342.541. This is 16.1% higher than average price of previous purchases of RO.SW. |
| BSX - Boston Scientific Corporation | BUY | 389 @ USD 98.04 | USD 38,138 | The ETF bought 389 new shares of BSX (Boston Scientific Corporation). The shares were bought for an average price of 98.04 compared to the previous average buy price of 101.285. This is -3.2% lower than average price of previous purchases of BSX. |
| BSX - MULSTRXSSXIMETFP | BUY | 389 @ USD 98.04 | USD 38,138 | The ETF bought 389 new shares of BSX (MULSTRXSSXIMETFP). The shares were bought for an average price of 98.04 compared to the previous average buy price of 101.285. This is -3.2% lower than average price of previous purchases of BSX. |
| HCA - HCA Holdings Inc | BUY | 47 @ USD 501.04 | USD 23,549 | The ETF bought 47 new shares of HCA (HCA Holdings Inc). The shares were bought for an average price of 501.04 compared to the previous average buy price of 434.61. This is 15.3% higher than average price of previous purchases of HCA. |
| DEMANT.CO - | BUY | 434 @ DKK 33.5618 | DKK 14,566 | The ETF bought 434 new shares of DEMANT.CO (). The shares were bought for an average price of 33.5618 compared to the previous average buy price of 36.0082. This is -6.8% lower than average price of previous purchases of DEMANT.CO. |
| BDX - Becton Dickinson and Company | BUY | 73 @ USD 190.96 | USD 13,940 | The ETF bought 73 new shares of BDX (Becton Dickinson and Company). The shares were bought for an average price of 190.96 compared to the previous average buy price of 182.974. This is 4.4% higher than average price of previous purchases of BDX. |
| LONN.SW - | BUY | 18 @ CHF 662.127 | CHF 11,918 | The ETF bought 18 new shares of LONN.SW (). The shares were bought for an average price of 662.127 compared to the previous average buy price of 677.655. This is -2.3% lower than average price of previous purchases of LONN.SW. |
| GEHC - GE HealthCare Technologies Inc. | BUY | 117 @ USD 78.24 | USD 9,154 | The ETF bought 117 new shares of GEHC (GE HealthCare Technologies Inc.). The shares were bought for an average price of 78.24 compared to the previous average buy price of 75.2601. This is 4.0% higher than average price of previous purchases of GEHC. |
| NTRA - Natera Inc | BUY | 38 @ USD 238.58 | USD 9,066 | The ETF bought 38 new shares of NTRA (Natera Inc). The shares were bought for an average price of 238.58 compared to the previous average buy price of 171.24. This is 39.3% higher than average price of previous purchases of NTRA. |
| BAYN.DE - Bayer AG | BUY | 243 @ EUR 35.2745 | EUR 8,572 | The ETF bought 243 new shares of BAYN.DE (Bayer AG). The shares were bought for an average price of 35.2745 compared to the previous average buy price of 31.2099. This is 13.0% higher than average price of previous purchases of BAYN.DE. |
| SDZ.SW - | BUY | 113 @ CHF 68.8375 | CHF 7,779 | The ETF bought 113 new shares of SDZ.SW (). The shares were bought for an average price of 68.8375 compared to the previous average buy price of 57.5322. This is 19.7% higher than average price of previous purchases of SDZ.SW. |
| TEVA - Teva Pharma Industries Ltd ADR | BUY | 310 @ USD 24.77 | USD 7,679 | The ETF bought 310 new shares of TEVA (Teva Pharma Industries Ltd ADR). The shares were bought for an average price of 24.77 compared to the previous average buy price of 18.796. This is 31.8% higher than average price of previous purchases of TEVA. |
| FRE.DE - Fresenius SE & Co KGaA | BUY | 116 @ EUR 54.4193 | EUR 6,313 | The ETF bought 116 new shares of FRE.DE (Fresenius SE & Co KGaA). The shares were bought for an average price of 54.4193 compared to the previous average buy price of 52.3188. This is 4.0% higher than average price of previous purchases of FRE.DE. |
| LH - Laboratory Corporation of America Holdings | BUY | 21 @ USD 265.31 | USD 5,572 | The ETF bought 21 new shares of LH (Laboratory Corporation of America Holdings). The shares were bought for an average price of 265.31 compared to the previous average buy price of 262.344. This is 1.1% higher than average price of previous purchases of LH. |
| DGX - Quest Diagnostics Incorporated | BUY | 28 @ USD 190.58 | USD 5,336 | The ETF bought 28 new shares of DGX (Quest Diagnostics Incorporated). The shares were bought for an average price of 190.58 compared to the previous average buy price of 180.134. This is 5.8% higher than average price of previous purchases of DGX. |
| UTHR - United Therapeutics Corporation | BUY | 11 @ USD 477.2 | USD 5,249 | The ETF bought 11 new shares of UTHR (United Therapeutics Corporation). The shares were bought for an average price of 477.2 compared to the previous average buy price of 415.643. This is 14.8% higher than average price of previous purchases of UTHR. |
| WST - West Pharmaceutical Services Inc | BUY | 19 @ USD 273.99 | USD 5,206 | The ETF bought 19 new shares of WST (West Pharmaceutical Services Inc). The shares were bought for an average price of 273.99 compared to the previous average buy price of 263.689. This is 3.9% higher than average price of previous purchases of WST. |
| ZBH - Zimmer Biomet Holdings Inc | BUY | 54 @ USD 93.5199 | USD 5,050 | The ETF bought 54 new shares of ZBH (Zimmer Biomet Holdings Inc). The shares were bought for an average price of 93.5199 compared to the previous average buy price of 97.5107. This is -4.1% lower than average price of previous purchases of ZBH. |
| ILMN - Illumina Inc | BUY | 40 @ USD 125.96 | USD 5,038 | The ETF bought 40 new shares of ILMN (Illumina Inc). The shares were bought for an average price of 125.96 compared to the previous average buy price of 101.567. This is 24.0% higher than average price of previous purchases of ILMN. |
| SHL.DE - Siemens Healthineers AG | BUY | 92 @ EUR 48.6315 | EUR 4,474 | The ETF bought 92 new shares of SHL.DE (Siemens Healthineers AG). The shares were bought for an average price of 48.6315 compared to the previous average buy price of 53.6245. This is -9.3% lower than average price of previous purchases of SHL.DE. |
| MRK.DE - Merck KGaA | BUY | 34 @ EUR 130.053 | EUR 4,422 | The ETF bought 34 new shares of MRK.DE (Merck KGaA). The shares were bought for an average price of 130.053 compared to the previous average buy price of 130.471. This is -0.3% lower than average price of previous purchases of MRK.DE. |
| RPRX - Royalty Pharma Plc | BUY | 108 @ USD 39.75 | USD 4,293 | The ETF bought 108 new shares of RPRX (Royalty Pharma Plc). The shares were bought for an average price of 39.75 compared to the previous average buy price of 36.5917. This is 8.6% higher than average price of previous purchases of RPRX. |
| SOLV - Solventum Corp. | BUY | 50 @ USD 83.3799 | USD 4,169 | The ETF bought 50 new shares of SOLV (Solventum Corp.). The shares were bought for an average price of 83.3799 compared to the previous average buy price of 72.0872. This is 15.7% higher than average price of previous purchases of SOLV. |
| ORNBV.HE - Orion Oyj | BUY | 60 @ EUR 69.2924 | EUR 4,158 | The ETF bought 60 new shares of ORNBV.HE (Orion Oyj). The shares were bought for an average price of 69.2924 compared to the previous average buy price of 67.7895. This is 2.2% higher than average price of previous purchases of ORNBV.HE. |
| DIM.PA - Sartorius Stedim Biotech | BUY | 18 @ EUR 224.307 | EUR 4,038 | The ETF bought 18 new shares of DIM.PA (Sartorius Stedim Biotech). The shares were bought for an average price of 224.307 compared to the previous average buy price of 220.724. This is 1.6% higher than average price of previous purchases of DIM.PA. |
| IPN.PA - Ipsen SA | BUY | 27 @ EUR 147.116 | EUR 3,972 | The ETF bought 27 new shares of IPN.PA (Ipsen SA). The shares were bought for an average price of 147.116 compared to the previous average buy price of 135.358. This is 8.7% higher than average price of previous purchases of IPN.PA. |
| SN.L - Smith & Nephew PLC | BUY | 229 @ GBP 16.4505 | GBP 3,767 | The ETF bought 229 new shares of SN.L (Smith & Nephew PLC). The shares were bought for an average price of 16.4505 compared to the previous average buy price of 17.3473. This is -5.2% lower than average price of previous purchases of SN.L. |
| ERF.PA - Eurofins Scientific SE | BUY | 55 @ EUR 67.4475 | EUR 3,710 | The ETF bought 55 new shares of ERF.PA (Eurofins Scientific SE). The shares were bought for an average price of 67.4475 compared to the previous average buy price of 69.5125. This is -3.0% lower than average price of previous purchases of ERF.PA. |
| REC.MI - Recordati Industria Chimica e Farmaceutica SpA | BUY | 63 @ EUR 57.7627 | EUR 3,639 | The ETF bought 63 new shares of REC.MI (Recordati Industria Chimica e Farmaceutica SpA). The shares were bought for an average price of 57.7627 compared to the previous average buy price of 58.4756. This is -1.2% lower than average price of previous purchases of REC.MI. |
| FME.DE - Fresenius Medical Care AG | BUY | 73 @ EUR 47.7321 | EUR 3,484 | The ETF bought 73 new shares of FME.DE (Fresenius Medical Care AG). The shares were bought for an average price of 47.7321 compared to the previous average buy price of 51.1715. This is -6.7% lower than average price of previous purchases of FME.DE. |
| GRF.MC - Grifols SA | BUY | 283 @ EUR 11.8754 | EUR 3,361 | The ETF bought 283 new shares of GRF.MC (Grifols SA). The shares were bought for an average price of 11.8754 compared to the previous average buy price of 13.2982. This is -10.7% lower than average price of previous purchases of GRF.MC. |
| PME.AX - | BUY | 20 @ AUD 167.928 | AUD 3,359 | The ETF bought 20 new shares of PME.AX (). The shares were bought for an average price of 167.928 compared to the previous average buy price of 182.072. This is -7.8% lower than average price of previous purchases of PME.AX. |
| FPH.NZ - | BUY | 157 @ NZD 20.929 | NZD 3,286 | The ETF bought 157 new shares of FPH.NZ (). The shares were bought for an average price of 20.929 compared to the previous average buy price of 21.1379. This is -1.0% lower than average price of previous purchases of FPH.NZ. |
| COH.AX - | BUY | 12 @ AUD 176.491 | AUD 2,118 | The ETF bought 12 new shares of COH.AX (). The shares were bought for an average price of 176.491 compared to the previous average buy price of 185.84. This is -5.0% lower than average price of previous purchases of COH.AX. |
| 2413.T - M3, Inc. | HOLD | 0 @ JPY 16.8054 | JPY 0 | The current share valuation price of 2413.T based on adjusted close was JPY 16.8054. The average price that 2413.T shares were previous bought at was JPY 14.2936. The current market price is 17.6% higher than average price they were purchased at. The value of the holding in 2413.T has fallen by JPY 621 (USD $4) compared to the previous valuation of M3, Inc. |
| 4151.T - Kyowa Kirin Co., Ltd. | HOLD | 0 @ JPY 16.3749 | JPY 0 | The current share valuation price of 4151.T based on adjusted close was JPY 16.3749. The average price that 4151.T shares were previous bought at was JPY 15.6107. The current market price is 4.9% higher than average price they were purchased at. The value of the holding in 4151.T has fallen by JPY 2,340 (USD $15) compared to the previous valuation of Kyowa Kirin Co., Ltd. |
| 4502.T - Takeda Pharmaceutical Company Limited | HOLD | 0 @ JPY 28.2981 | JPY 0 | The current share valuation price of 4502.T based on adjusted close was JPY 28.2981. The average price that 4502.T shares were previous bought at was JPY 28.7904. The current market price is -1.7% lower than average price they were purchased at. The value of the holding in 4502.T has fallen by JPY 1,458 (USD $9) compared to the previous valuation of Takeda Pharmaceutical Company Limited |
| 4503.T - Astellas Pharma Inc. | HOLD | 0 @ JPY 12.5291 | JPY 0 | The current share valuation price of 4503.T based on adjusted close was JPY 12.5291. The average price that 4503.T shares were previous bought at was JPY 10.7471. The current market price is 16.6% higher than average price they were purchased at. The value of the holding in 4503.T has fallen by JPY 9,736 (USD $62) compared to the previous valuation of Astellas Pharma Inc. |
| 4507.T - Shionogi & Co., Ltd. | HOLD | 0 @ JPY 17.2008 | JPY 0 | The current share valuation price of 4507.T based on adjusted close was JPY 17.2008. The average price that 4507.T shares were previous bought at was JPY 16.8555. The current market price is 2.0% higher than average price they were purchased at. The value of the holding in 4507.T has fallen by JPY 404 (USD $3) compared to the previous valuation of Shionogi & Co., Ltd. |
| 4519.T - Chugai Pharmaceutical Co., Ltd. | HOLD | 0 @ JPY 53.369 | JPY 0 | The current share valuation price of 4519.T based on adjusted close was JPY 53.369. The average price that 4519.T shares were previous bought at was JPY 46.3112. The current market price is 15.2% higher than average price they were purchased at. The value of the holding in 4519.T has fallen by JPY 6,537 (USD $42) compared to the previous valuation of Chugai Pharmaceutical Co., Ltd. |
| 4523.T - Eisai Co., Ltd. | HOLD | 0 @ JPY 29.8288 | JPY 0 | The current share valuation price of 4523.T based on adjusted close was JPY 29.8288. The average price that 4523.T shares were previous bought at was JPY 30.2753. The current market price is -1.5% lower than average price they were purchased at. The value of the holding in 4523.T has fallen by JPY 4,673 (USD $30) compared to the previous valuation of Eisai Co., Ltd. |
| 4543.T - Terumo Corporation | HOLD | 0 @ JPY 15.6893 | JPY 0 | The current share valuation price of 4543.T based on adjusted close was JPY 15.6893. The average price that 4543.T shares were previous bought at was JPY 16.6368. The current market price is -5.7% lower than average price they were purchased at. The value of the holding in 4543.T has fallen by JPY 686 (USD $4) compared to the previous valuation of Terumo Corporation |
| 4568.T - Daiichi Sankyo Company, Limited | HOLD | 0 @ JPY 23.5977 | JPY 0 | The current share valuation price of 4568.T based on adjusted close was JPY 23.5977. The average price that 4568.T shares were previous bought at was JPY 24.0521. The current market price is -1.9% lower than average price they were purchased at. The value of the holding in 4568.T has fallen by JPY 8,421 (USD $54) compared to the previous valuation of Daiichi Sankyo Company, Limited |
| 4578.T - Otsuka Holdings Co., Ltd. | HOLD | 0 @ JPY 54.6382 | JPY 0 | The current share valuation price of 4578.T based on adjusted close was JPY 54.6382. The average price that 4578.T shares were previous bought at was JPY 53.253. The current market price is 2.6% higher than average price they were purchased at. The value of the holding in 4578.T has fallen by JPY 762 (USD $5) compared to the previous valuation of Otsuka Holdings Co., Ltd. |
| 6869.T - Sysmex Corporation | HOLD | 0 @ JPY 9.93973 | JPY 0 | The current share valuation price of 6869.T based on adjusted close was JPY 9.93973. The average price that 6869.T shares were previous bought at was JPY 12.6105. The current market price is -21.2% lower than average price they were purchased at. The value of the holding in 6869.T has fallen by JPY 3,036 (USD $19) compared to the previous valuation of Sysmex Corporation |
| 7733.T - Olympus Corporation | HOLD | 0 @ JPY 13.2115 | JPY 0 | The current share valuation price of 7733.T based on adjusted close was JPY 13.2115. The average price that 7733.T shares were previous bought at was JPY 12.5576. The current market price is 5.2% higher than average price they were purchased at. The value of the holding in 7733.T has fallen by JPY 499 (USD $3) compared to the previous valuation of Olympus Corporation |
| 7741.T - HOYA Corporation | HOLD | 0 @ JPY 147.39 | JPY 0 | The current share valuation price of 7741.T based on adjusted close was JPY 147.39. The average price that 7741.T shares were previous bought at was JPY 145.171. The current market price is 1.5% higher than average price they were purchased at. The value of the holding in 7741.T has fallen by JPY 2,531 (USD $16) compared to the previous valuation of HOYA Corporation |
| PHIA.AS - Koninklijke Philips NV | SELL | -1,679 @ EUR 27.4287 | EUR -46,053 | The ETF sold 1679 shares of PHIA.AS on 2025-11-24. The shares were previously bought for an average price of EUR 26.5139. The Koninklijke Philips NV shares were sold for 3.5% higher than average price of previous purchases. This sale made a profit of EUR 1,536 (USD $1,768) The average price that the ETF previously sold PHIA.AS share for is EUR 25.1294 so the ETF has sold 1679 shares on 2025-11-24 at a higher price than the previous selling average. |
| NBIX - Neurocrine Biosciences Inc | SELL | -349 @ USD 141.25 | USD -49,296 | The ETF sold 349 shares of NBIX on 2025-11-24. The shares were previously bought for an average price of USD 140.213. The Neurocrine Biosciences Inc shares were sold for 0.7% higher than average price of previous purchases. This sale made a profit of USD 362 The average price that the ETF previously sold NBIX share for is USD 125.676 so the ETF has sold 349 shares on 2025-11-24 at a higher price than the previous selling average. |
| VEEV - Veeva Systems Inc Class A | SELL | -359 @ USD 235.74 | USD -84,631 | The ETF sold 359 shares of VEEV on 2025-11-24. The shares were previously bought for an average price of USD 284.797. The Veeva Systems Inc Class A shares were sold for -17.2% lower than average price of previous purchases. This resulted in an overall loss of USD 17,611 The average price that the ETF previously sold VEEV share for is USD 279.099 which is higher than the selling price of USD 235.74 on 2025-11-24. |
| HUM - Hummingbird Resources PLC | SELL | -1,370 @ USD 229.2 | USD -314,004 | The ETF sold 1370 shares of HUM on 2025-11-24. The shares were previously bought for an average price of USD 267.564. The Hummingbird Resources PLC shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 52,559 The average price that the ETF previously sold HUM share for is USD 250.816 which is higher than the selling price of USD 229.2 on 2025-11-24. |
| HUM - Humana Inc | SELL | -1,370 @ USD 229.2 | USD -314,004 | The ETF sold 1370 shares of HUM on 2025-11-24. The shares were previously bought for an average price of USD 267.564. The Humana Inc shares were sold for -14.3% lower than average price of previous purchases. This resulted in an overall loss of USD 52,559 The average price that the ETF previously sold HUM share for is USD 250.816 which is higher than the selling price of USD 229.2 on 2025-11-24. |
| IDXX - IDEXX Laboratories Inc | SELL | -976 @ USD 752.14 | USD -734,089 | The ETF sold 976 shares of IDXX on 2025-11-24. The shares were previously bought for an average price of USD 609.637. The IDEXX Laboratories Inc shares were sold for 23.4% higher than average price of previous purchases. This sale made a profit of USD 139,083 The average price that the ETF previously sold IDXX share for is USD 543.668 so the ETF has sold 976 shares on 2025-11-24 at a higher price than the previous selling average. |
| NOVN.SW - | SELL | -6,031 @ CHF 127.523 | CHF -769,091 | The ETF sold 6031 shares of NOVN.SW on 2025-11-24. The shares were previously bought for an average price of CHF 123.74. The shares were sold for 3.1% higher than average price of previous purchases. This sale made a profit of CHF 22,815 (USD $28,208) The average price that the ETF previously sold NOVN.SW share for is CHF 120.135 so the ETF has sold 6031 shares on 2025-11-24 at a higher price than the previous selling average. |
| UCB.BR - UCB SA | SELL | -3,266 @ EUR 272.212 | EUR -889,044 | The ETF sold 3266 shares of UCB.BR on 2025-11-24. The shares were previously bought for an average price of EUR 248.44. The UCB SA shares were sold for 9.6% higher than average price of previous purchases. This sale made a profit of EUR 77,639 (USD $89,342) The average price that the ETF previously sold UCB.BR share for is EUR 210.016 so the ETF has sold 3266 shares on 2025-11-24 at a higher price than the previous selling average. |
| HOLX - Hologic Inc | SELL | -13,252 @ USD 74.76 | USD -990,720 | The ETF sold 13252 shares of HOLX on 2025-11-24. The shares were previously bought for an average price of USD 69.7374. The Hologic Inc shares were sold for 7.2% higher than average price of previous purchases. This sale made a profit of USD 66,559 The average price that the ETF previously sold HOLX share for is USD 64.3427 so the ETF has sold 13252 shares on 2025-11-24 at a higher price than the previous selling average. |
| SRT3.DE - Sartorius AG | SELL | -3,720 @ EUR 266.908 | EUR -992,898 | The ETF sold 3720 shares of SRT3.DE on 2025-11-24. The shares were previously bought for an average price of EUR 254.653. The Sartorius AG shares were sold for 4.8% higher than average price of previous purchases. This sale made a profit of EUR 45,589 (USD $52,461) The average price that the ETF previously sold SRT3.DE share for is EUR 247.044 so the ETF has sold 3720 shares on 2025-11-24 at a higher price than the previous selling average. |
| CNC - Concurrent Technologies Plc | SELL | -26,219 @ USD 38.17 | USD -1,000,779 | The ETF sold 26219 shares of CNC on 2025-11-24. The shares were previously bought for an average price of USD 38.4416. The Concurrent Technologies Plc shares were sold for -0.7% lower than average price of previous purchases. This resulted in an overall loss of USD 7,121 The average price that the ETF previously sold CNC share for is USD 54.8249 which is higher than the selling price of USD 38.17 on 2025-11-24. |
| GILD - Guild Esports Plc | SELL | -9,154 @ USD 125.27 | USD -1,146,722 | The ETF sold 9154 shares of GILD on 2025-11-24. The shares were previously bought for an average price of USD 116.15. The Guild Esports Plc shares were sold for 7.9% higher than average price of previous purchases. This sale made a profit of USD 83,484 The average price that the ETF previously sold GILD share for is USD 111.663 so the ETF has sold 9154 shares on 2025-11-24 at a higher price than the previous selling average. |
| NOVO-B.CO - Novo Nordisk A/S | SELL | -34,875 @ DKK 44.3065 | DKK -1,545,189 | The ETF sold 34875 shares of NOVO-B.CO on 2025-11-24. The shares were previously bought for an average price of DKK 55.9384. The Novo Nordisk A/S shares were sold for -20.8% lower than average price of previous purchases. This resulted in an overall loss of DKK 405,663 (USD $62,511) The average price that the ETF previously sold NOVO-B.CO share for is DKK 69.7209 which is higher than the selling price of DKK 44.3065 on 2025-11-24. |
| STE - STERIS plc | SELL | -6,466 @ USD 263.08 | USD -1,701,075 | The ETF sold 6466 shares of STE on 2025-11-24. The shares were previously bought for an average price of USD 240.814. The STERIS plc shares were sold for 9.2% higher than average price of previous purchases. This sale made a profit of USD 143,972 The average price that the ETF previously sold STE share for is USD 237.402 so the ETF has sold 6466 shares on 2025-11-24 at a higher price than the previous selling average. |
| ALC.SW - | SELL | -24,236 @ CHF 76.2412 | CHF -1,847,782 | The ETF sold 24236 shares of ALC.SW on 2025-11-24. The shares were previously bought for an average price of CHF 77.7293. The shares were sold for -1.9% lower than average price of previous purchases. This resulted in an overall loss of CHF 36,066 (USD $44,600) The average price that the ETF previously sold ALC.SW share for is CHF 83.1726 which is higher than the selling price of CHF 76.2412 on 2025-11-24. |
| WAT - Waters Corporation | SELL | -4,938 @ USD 399.54 | USD -1,972,929 | The ETF sold 4938 shares of WAT on 2025-11-24. The shares were previously bought for an average price of USD 337.329. The Waters Corporation shares were sold for 18.4% higher than average price of previous purchases. This sale made a profit of USD 307,198 The average price that the ETF previously sold WAT share for is USD 327.282 so the ETF has sold 4938 shares on 2025-11-24 at a higher price than the previous selling average. |
| WAT - MULETFWATIMETFP | SELL | -4,938 @ USD 399.54 | USD -1,972,929 | The ETF sold 4938 shares of WAT on 2025-11-24. The shares were previously bought for an average price of USD 337.329. The MULETFWATIMETFP shares were sold for 18.4% higher than average price of previous purchases. This sale made a profit of USD 307,198 The average price that the ETF previously sold WAT share for is USD 327.282 so the ETF has sold 4938 shares on 2025-11-24 at a higher price than the previous selling average. |
| CI - Cigna Corp | SELL | -7,540 @ USD 271.47 | USD -2,046,884 | The ETF sold 7540 shares of CI on 2025-11-24. The shares were previously bought for an average price of USD 291.006. The Cigna Corp shares were sold for -6.7% lower than average price of previous purchases. This resulted in an overall loss of USD 147,301 The average price that the ETF previously sold CI share for is USD 313.719 which is higher than the selling price of USD 271.47 on 2025-11-24. |
| ELV - Elevance Health Inc | SELL | -6,930 @ USD 329.6 | USD -2,284,128 | The ETF sold 6930 shares of ELV on 2025-11-24. The shares were previously bought for an average price of USD 335.766. The Elevance Health Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 42,730 The average price that the ETF previously sold ELV share for is USD 366.351 which is higher than the selling price of USD 329.6 on 2025-11-24. |
| ELV - Elevance Health Inc | SELL | -6,930 @ USD 329.6 | USD -2,284,128 | The ETF sold 6930 shares of ELV on 2025-11-24. The shares were previously bought for an average price of USD 335.766. The Elevance Health Inc shares were sold for -1.8% lower than average price of previous purchases. This resulted in an overall loss of USD 42,730 The average price that the ETF previously sold ELV share for is USD 366.351 which is higher than the selling price of USD 329.6 on 2025-11-24. |
| IQV - IQVIA Holdings Inc | SELL | -10,036 @ USD 228.18 | USD -2,290,014 | The ETF sold 10036 shares of IQV on 2025-11-24. The shares were previously bought for an average price of USD 195.252. The IQVIA Holdings Inc shares were sold for 16.9% higher than average price of previous purchases. This sale made a profit of USD 330,465 The average price that the ETF previously sold IQV share for is USD 180.378 so the ETF has sold 10036 shares on 2025-11-24 at a higher price than the previous selling average. |
| VRTX - Vertex Pharmaceuticals Inc | SELL | -5,866 @ USD 424 | USD -2,487,184 | The ETF sold 5866 shares of VRTX on 2025-11-24. The shares were previously bought for an average price of USD 423.38. The Vertex Pharmaceuticals Inc shares were sold for 0.1% higher than average price of previous purchases. This sale made a profit of USD 3,637 The average price that the ETF previously sold VRTX share for is USD 443.758 which is higher than the selling price of USD 424 on 2025-11-24. |
| EW - Edwards Lifesciences Corp | SELL | -29,496 @ USD 84.71 | USD -2,498,606 | The ETF sold 29496 shares of EW on 2025-11-24. The shares were previously bought for an average price of USD 78.715. The Edwards Lifesciences Corp shares were sold for 7.6% higher than average price of previous purchases. This sale made a profit of USD 176,829 The average price that the ETF previously sold EW share for is USD 77.847 so the ETF has sold 29496 shares on 2025-11-24 at a higher price than the previous selling average. |
| GMAB.CO - | SELL | -8,607 @ DKK 309.683 | DKK -2,665,442 | The ETF sold 8607 shares of GMAB.CO on 2025-11-24. The shares were previously bought for an average price of DKK 280.97. The shares were sold for 10.2% higher than average price of previous purchases. This sale made a profit of DKK 247,133 (USD $38,081) The average price that the ETF previously sold GMAB.CO share for is DKK 234.665 so the ETF has sold 8607 shares on 2025-11-24 at a higher price than the previous selling average. |
| MCK - McKesson Corporation | SELL | -5,422 @ USD 870.21 | USD -4,718,279 | The ETF sold 5422 shares of MCK on 2025-11-24. The shares were previously bought for an average price of USD 778.024. The McKesson Corporation shares were sold for 11.8% higher than average price of previous purchases. This sale made a profit of USD 499,832 The average price that the ETF previously sold MCK share for is USD 717.053 so the ETF has sold 5422 shares on 2025-11-24 at a higher price than the previous selling average. |
| COR - Cencora Inc. | SELL | -13,002 @ USD 372.22 | USD -4,839,604 | The ETF sold 13002 shares of COR on 2025-11-24. The shares were previously bought for an average price of USD 320.421. The Cencora Inc. shares were sold for 16.2% higher than average price of previous purchases. This sale made a profit of USD 673,491 The average price that the ETF previously sold COR share for is USD 290.294 so the ETF has sold 13002 shares on 2025-11-24 at a higher price than the previous selling average. |
| A - Agilent Technologies Inc | SELL | -34,924 @ USD 153.6 | USD -5,364,326 | The ETF sold 34924 shares of A on 2025-11-24. The shares were previously bought for an average price of USD 134.498. The Agilent Technologies Inc shares were sold for 14.2% higher than average price of previous purchases. This sale made a profit of USD 667,118 The average price that the ETF previously sold A share for is USD 118.029 so the ETF has sold 34924 shares on 2025-11-24 at a higher price than the previous selling average. |
| CAH - Cardinal Health Inc | SELL | -26,341 @ USD 211.2 | USD -5,563,219 | The ETF sold 26341 shares of CAH on 2025-11-24. The shares were previously bought for an average price of USD 167.417. The Cardinal Health Inc shares were sold for 26.2% higher than average price of previous purchases. This sale made a profit of USD 1,153,288 The average price that the ETF previously sold CAH share for is USD 151.693 so the ETF has sold 26341 shares on 2025-11-24 at a higher price than the previous selling average. |
| AZN.L - AstraZeneca PLC | SELL | -38,055 @ GBP 182.501 | GBP -6,945,076 | The ETF sold 38055 shares of AZN.L on 2025-11-24. The shares were previously bought for an average price of GBP 159.117. The AstraZeneca PLC shares were sold for 14.7% higher than average price of previous purchases. This sale made a profit of GBP 889,878 (USD $1,165,393) The average price that the ETF previously sold AZN.L share for is GBP 149.388 so the ETF has sold 38055 shares on 2025-11-24 at a higher price than the previous selling average. |